Center-Authored Papers

Filters: Author is Catalona, William J  [Clear All Filters]
Journal Article
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O et al..  2014.  Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.. Human genetics. 133(3):347-56. Abstract
Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu J-N, Bauer S, Van Blarigan EL, Chen X et al..  2015.  Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.. Human genetics. 134(4):439-50. Abstract
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TLJ et al..  2012.  Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.. The Prostate. 72(4):410-426. Abstract
Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ et al..  2016.  Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.. Human genetics. Abstract
Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM et al..  2013.  HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).. Human genetics. 132(1):5-14. Abstract
Kawachi MH, Bahnson RR, Barry M, Busby EJ, Carroll PR, Carter BH, Catalona WJ, Cookson MS, Epstein JI, Etzioni R et al..  2010.  NCCN clinical practice guidelines in oncology: prostate cancer early detection.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(2):240-62.
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB et al..  2016.  NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(5):509-19. Abstract
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI et al..  2015.  Prostate Cancer Early Detection, Version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(12):1534-61. Abstract
Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D et al..  2016.  REVEL: an Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.. American journal of human genetics. 99(4):877-885. Abstract
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM et al..  2012.  Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).. Human genetics. 131(7):1095-1103. Abstract